SOLUBLE CD33 FOR TREATING MYELODYSPLASTIC SYNDROMES (MDS)

摘要

Disclosed are compositions and methods for treating disease or condition caused or exacerbated by S100A9 activity, such as myelodysplastic syndromes (MDS) using a composition comprising an effective amount of a CD33/S100A9 inhibitor.